Discovery of immune cells able to defend against mutating viruses could transform vaccine development

May 1, 2018, University of Exeter
Credit: CC0 Public Domain

Scientists have found immune cells can fight different strains of the same virus—a discovery which could help transform vaccine development.

Vaccines become ineffective when a mutates, and tackling this problem is a priority for researchers. Vaccinations aim to stimulate the body to produce "memory" cells which provide long-lasting protection from disease. Until now it was thought that these cells could only remember—and be able to protect against—one particular strain of virus.

Researchers have now found the immune system can produce memory cells which have the ability to recognise different strains of the same virus, rather than just one. This could help scientists transform the way vaccines are produced and given.

Diseases such as influenza, Dengue fever and AIDS are caused by viruses which constantly mutate, allowing them to hide from the immune system and evade any response from their host. Current vaccines can provide good protection against particular strains of virus but fail to protect against new strains caused by genetic mutation. For this reason the influenza , for example, has to be updated and administered annually, often with limited success, to pre-empt the appearance of new variant viruses.

Dr. Harry White, from the University of Exeter, who led the Wellcome Trust-funded research, said: "Trying to find vaccines which can protect people against different strains of virus is a focus for scientists around the world. So far, despite a large global effort, there has been limited success in the war against virus mutation.

"We have found the immune system is able to recognise threats from new strains of a virus. We have long known of the existence of different types of immune memory cells, and now we know what these differences mean.

"After exposure to one strain of virus, these memory cells are then better able to recognise variants of the virus if they encounter them in the future. The immune system learns to protect against a whole group of related viruses, not just the one it experienced. It is this property that needs to be exploited to help make broadly protective vaccines."

The memory cells examined in this study are immature, or less developed, which allows them to more easily change and adapt to fight different viral strains. The antibodies from these cells are less focused on the infecting virus, but this is an advantage if the virus has mutated.

The research involved academics from the University of Exeter, University of Bristol and University of Birmingham testing the reaction of mice vaccinated with proteins from different strains of virus. Through painstakingly isolating hundreds of different individual cells and analysing the different antibodies each one made they were able to detect the presence of the immature cells that made these less focused antibodies. The mice which were immunised sequentially with proteins from different strains of the same virus produced more of these less developed memory cells.

Professor Rick Titball said "The holy grail for many scientists is to find a way of developing vaccines which work against all of a microorganism. This work could bring us a step closer to this and avoid, for example, the need to develop a new flu vaccine each year"

'Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory' is published in the journal eLife.

Explore further: Strategy introduces stable components of flu virus for long-lasting, DNA-enhanced protection

Related Stories

Strategy introduces stable components of flu virus for long-lasting, DNA-enhanced protection

January 5, 2018
Getting a flu shot every year can be a pain. One UW Medicine researcher is hoping to make the yearly poke a thing of the past with the development of a universal vaccine that would protect from all strains of influenza virus, ...

Intranasal flu vaccine produces long-lasting immune response in mice

July 19, 2016
Intranasal flu vaccines may be able to provide long-lasting protection against pandemic flu strains, according to a new study from immunologists at Columbia University Medical Center (CUMC).

Flu-fighting cells in noses could lead to one-shot flu vaccine

June 5, 2017
A sneeze is often the first sign of a cold or flu. But a sneeze, or more accurately our noses, could be the secret to stopping the influenza virus in its tracks through what scientists are calling a "nasal border patrol".

How flu shot manufacturing forces influenza to mutate

October 30, 2017
According to a new study from scientists at The Scripps Research Institute (TSRI), the common practice of growing influenza vaccine components in chicken eggs disrupts the major antibody target site on the virus surface, ...

Simple strategy could lead to a 'universal' flu vaccine

October 2, 2017
It's that time of year again: Temperatures drop, sleeves go up, and the needles come out. If scientists at The Rockefeller University have their way, however, the annual ritual of the flu shot could become obsolete.

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.